01 / 03Scientific Integrity
Independent analytical results are presented as reported by the testing laboratory, without altering the laboratory’s findings.

Product images are for illustrative reference only. Final label layout and packaging details may vary by batch or production run. Product identity, strength and batch-specific documentation are provided separately and remain product-specific.
NOREXA PEPTIDES / RESEARCH MATERIAL
Research Laboratory Reagent — Single vial
Bacteriostatic Water 3 mL aqueous solution containing 0.9% benzyl alcohol (9 mg/mL), supplied exclusively as a laboratory research material.
Not for human or animal consumption.
Not intended to diagnose, treat, cure or prevent any disease.
TECHNICAL OVERVIEW
Bacteriostatic Water 3 mL is catalogued as an aqueous laboratory reagent containing 0.9% benzyl alcohol, equivalent to 9 mg/mL. It is not a peptide and is therefore presented with a separate technical structure.
The benzyl alcohol functions as a bacteriostatic preservative in the solution. The NOREXA page does not claim USP status, sterility, pyrogen status or suitability for clinical administration unless those attributes are supported by batch-specific documentation.
For research use only. Not for human or veterinary use. Published findings describe the compound or related research systems; they are not claims about this NOREXA batch.
SCIENTIFIC CONTEXT
Longer technical information is grouped for easier reading on desktop and mobile.
Follow the current batch label and documentation. A NOREXA batch-specific post-opening hold time is not currently published, and no comparator product's duration has been transferred to this 3 mL reagent.
Use only where the solution remains clear, the container is intact and the applicable laboratory protocol confirms compatibility with 0.9% benzyl alcohol.
INDEPENDENT VERIFICATION
Purity alone is not enough. NOREXA distinguishes identity, purity and actual quantity, and publishes results only for the exact batch tested.
CURRENT BATCH / LOT
No identity, purity, quantity or batch number is shown as independently verified until exact product-and-lot evidence is available.
OPEN CENTRAL BATCH VERIFICATION →HISTORICAL BATCHES
No historical batch records are currently published for this product.
PRODUCT INFORMATION
Verified identity and catalogue information for this NOREXA research material. Unconfirmed fields are omitted.
SELECTED SOURCES
Selected literature describes the compound and relevant research pathways; it does not constitute testing or endorsement of this NOREXA batch.
DailyMed / U.S. National Library of Medicine
PubChem / National Center for Biotechnology Information
These references document the preservative and a comparator composition. They do not establish USP, sterile or clinical status for the NOREXA product.
PRODUCT FAQ
3 mL aqueous solution containing 0.9% benzyl alcohol, equivalent to 9 mg/mL.
No. It is an aqueous laboratory reagent and uses a dedicated technical template.
No. Solvent compatibility must be established for the exact compound, molecular form, concentration and assay.
Not for the current NOREXA batch. The page does not copy a hold time from a different product or container.
SECTION 01 — STANDARDS
01 / 03Independent analytical results are presented as reported by the testing laboratory, without altering the laboratory’s findings.
02 / 03Each batch is assigned a record linking the product to its available technical and independent testing documentation.
03 / 03Available batch documentation is organized under the corresponding batch number for clear reference.
NOREXA PEPTIDES
RESEARCH ACCESS
Please confirm before entering the website.
RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE